Foreign hyperlipemia drugs increase market share

Published: 2011-03-31 07:00:00
Updated: 2011-03-31 07:00:00
Foreign-made hyperlipemia medicines showed sustained growth of the sector’s domestic sales in February, an industry report showed recently.

According to Shinhan Investment Corp., Pfizer’s Lipitor and AstraZeneca’s Crestor showed a double-digit growth in February sales, reaching 11.7 percent an...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.